|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||399.390 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
RWJ-51204 is a nonselective partial agonist at GABAA receptors. It produces primarily anxiolytic effects at low doses, with sedative, ataxia and muscle relaxant effects only appearing at some 20x the effective anxiolytic dose. It was discovered by researchers at the pharmaceutical company Johnson & Johnson, but its development has been discontinued.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|